Suppr超能文献

泰国南部一家单一的四级转诊中心孕产妇严重并发症及血液系统疾病相关死亡情况分析

Analysis of Maternal Near-miss and Mortality with Hematologic Diseases in a Single Quaternary Referral Center in Southern Thailand.

作者信息

Peeyananjarassri Krantarat, Suwanrath Chitkasaem, Ratipann Ninizna, Chainarong Natthicha, Boonyapipat Sathana, Pinjaroen Sutham

机构信息

Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, 90110 Thailand.

出版信息

J Obstet Gynaecol India. 2025 Apr;75(Suppl 1):190-197. doi: 10.1007/s13224-025-02106-8. Epub 2025 Apr 11.

Abstract

PURPOSE

To assess the causes and clinical outcomes of maternal near-misses and mortality associated with hematologic diseases.

METHODS

We retrospectively reviewed the medical records from women who experienced maternal near-misses or mortality attributed to hematological diseases during pregnancy or within 42 days of pregnancy termination, following the World Health Organization criteria, at a single quaternary referral center in Southern Thailand, from 2006 to 2021.

RESULTS

A total of 109 cases were analyzed, including five maternal deaths and 104 near-miss cases related to hematologic diseases. The median (min-max) maternal age was 29 (14-43) years, with 57.8% of the women being multiparous. The most common hematologic diseases were immune thrombocytopenia (68.8%), acute leukemia (6.4%), and aplastic anemia (6.4%). Of these, 48.6% were diagnosed before pregnancy and 57.8% exhibited a platelet count < 50 × 10/L during the intrapartum period. Acute leukemia was the leading cause of death (3/5). Severe maternal outcomes in cases of immune thrombocytopenia were more frequently observed in women with platelet counts < 50 × 10/L.

CONCLUSION

The primary hematologic diseases causing maternal near-miss and mortality were immune thrombocytopenia, acute leukemia, and aplastic anemia. Acute leukemia was the leading cause of death.

摘要

目的

评估与血液系统疾病相关的孕产妇险些死亡和死亡的原因及临床结局。

方法

我们按照世界卫生组织的标准,回顾性分析了2006年至2021年在泰国南部一家单一的四级转诊中心,孕期或终止妊娠后42天内经历了因血液系统疾病导致的孕产妇险些死亡或死亡的女性的病历。

结果

共分析了109例病例,包括5例孕产妇死亡和104例与血液系统疾病相关的险些死亡病例。孕产妇年龄中位数(最小值 - 最大值)为29(14 - 43)岁,57.8%的女性为经产妇。最常见的血液系统疾病是免疫性血小板减少症(68.8%)、急性白血病(6.4%)和再生障碍性贫血(6.4%)。其中,48.6%在妊娠前被诊断出,57.8%在产时血小板计数<50×10⁹/L。急性白血病是主要死因(3/5)。血小板计数<50×10⁹/L的免疫性血小板减少症患者更常出现严重的孕产妇结局。

结论

导致孕产妇险些死亡和死亡的主要血液系统疾病是免疫性血小板减少症、急性白血病和再生障碍性贫血。急性白血病是主要死因。

相似文献

1
Analysis of Maternal Near-miss and Mortality with Hematologic Diseases in a Single Quaternary Referral Center in Southern Thailand.
J Obstet Gynaecol India. 2025 Apr;75(Suppl 1):190-197. doi: 10.1007/s13224-025-02106-8. Epub 2025 Apr 11.
2
Severe Maternal Morbidity and near Miss-Events in Women with Heart Disease: Insights from a Cohort Study.
Diagnostics (Basel). 2025 Jun 16;15(12):1524. doi: 10.3390/diagnostics15121524.
3
Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants.
Cochrane Database Syst Rev. 2018 Jan 5;1(1):CD012910. doi: 10.1002/14651858.CD012910.
4
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
6
Epidural therapy for the treatment of severe pre-eclampsia in non labouring women.
Cochrane Database Syst Rev. 2017 Nov 28;11(11):CD009540. doi: 10.1002/14651858.CD009540.pub2.
7
Treatment for women with postpartum iron deficiency anaemia.
Cochrane Database Syst Rev. 2024 Dec 13;12(12):CD010861. doi: 10.1002/14651858.CD010861.pub3.
9
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Cochrane Database Syst Rev. 2011 Jul 6(7):CD003510. doi: 10.1002/14651858.CD003510.pub3.
10
Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings.
Cochrane Database Syst Rev. 2016 Apr 14;4(4):CD011491. doi: 10.1002/14651858.CD011491.pub2.

本文引用的文献

1
An in-depth analysis of maternal mortality in a quaternary university hospital in Southern Thailand: A 16-year experience.
Int J Gynaecol Obstet. 2023 Nov;163(2):579-585. doi: 10.1002/ijgo.14856. Epub 2023 May 13.
2
Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study.
Blood. 2023 Jan 5;141(1):11-21. doi: 10.1182/blood.2022017277.
3
2021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy.
Chin Med J (Engl). 2022 Apr 20;135(8):887-889. doi: 10.1097/CM9.0000000000002043.
4
Maternal and Fetal Outcomes of Acute Leukemia in Pregnancy: A Retrospective Study of 52 Patients.
Front Oncol. 2021 Dec 14;11:803994. doi: 10.3389/fonc.2021.803994. eCollection 2021.
5
Platelet count and indices as postpartum hemorrhage risk factors: a retrospective cohort study.
J Thromb Haemost. 2021 Nov;19(11):2873-2883. doi: 10.1111/jth.15481. Epub 2021 Aug 20.
7
Mild Thrombocytopenia and Postpartum Hemorrhage in Nulliparous Women With Term, Singleton, Vertex Deliveries.
Obstet Gynecol. 2020 Jun;135(6):1338-1344. doi: 10.1097/AOG.0000000000003861.
8
Updated international consensus report on the investigation and management of primary immune thrombocytopenia.
Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812.
9
Immune Thrombocytopenic Purpura in Pregnancy.
Obstet Gynecol Surv. 2019 Aug;74(8):490-496. doi: 10.1097/OGX.0000000000000697.
10
ACOG Practice Bulletin No. 207: Thrombocytopenia in Pregnancy.
Obstet Gynecol. 2019 Mar;133(3):e181-e193. doi: 10.1097/AOG.0000000000003100.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验